PT83920B - Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem

Info

Publication number
PT83920B
PT83920B PT83920A PT8392086A PT83920B PT 83920 B PT83920 B PT 83920B PT 83920 A PT83920 A PT 83920A PT 8392086 A PT8392086 A PT 8392086A PT 83920 B PT83920 B PT 83920B
Authority
PT
Portugal
Prior art keywords
carbon atoms
alkyl
group
salts
morfolini
Prior art date
Application number
PT83920A
Other languages
English (en)
Other versions
PT83920A (fr
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of PT83920A publication Critical patent/PT83920A/pt
Publication of PT83920B publication Critical patent/PT83920B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT83920A 1985-12-13 1986-12-12 Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem PT83920B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518482A FR2591595B1 (fr) 1985-12-13 1985-12-13 Nouveaux derives du 4-morpholinyl 1h-indole, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant, et intermediaires

Publications (2)

Publication Number Publication Date
PT83920A PT83920A (fr) 1987-01-01
PT83920B true PT83920B (pt) 1989-06-30

Family

ID=9325757

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83920A PT83920B (pt) 1985-12-13 1986-12-12 Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem

Country Status (11)

Country Link
US (2) US4699907A (pt)
EP (1) EP0230179B1 (pt)
JP (1) JPS62148485A (pt)
AT (1) ATE81127T1 (pt)
CA (1) CA1266471A (pt)
DE (1) DE3686876T2 (pt)
ES (1) ES2043605T3 (pt)
FR (1) FR2591595B1 (pt)
GR (1) GR3006137T3 (pt)
HU (1) HU199458B (pt)
PT (1) PT83920B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69114210T2 (de) * 1990-08-13 1996-05-02 Hoechst Roussel Pharma Carbamoyl-1-(pyridinylalkyl)-1H-indole, -indoline und verwandte Verbindungen.
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
FR2792313A1 (fr) * 1999-04-13 2000-10-20 Synthelabo Derives de 2-aminoethyl-indole, leur preparation et leur application en therapeutique
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2501208A1 (fr) * 1981-09-17 1982-09-10 Roussel Uclaf Nouveaux derives du morpholinyl-indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et composition les renfermant
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation

Also Published As

Publication number Publication date
EP0230179A2 (fr) 1987-07-29
HUT45996A (en) 1988-09-28
EP0230179A3 (en) 1988-05-18
HU199458B (en) 1990-02-28
ATE81127T1 (de) 1992-10-15
DE3686876D1 (de) 1992-11-05
US4699907A (en) 1987-10-13
FR2591595B1 (fr) 1988-09-09
DE3686876T2 (de) 1993-05-06
CA1266471A (fr) 1990-03-06
FR2591595A1 (fr) 1987-06-19
ES2043605T3 (es) 1994-01-01
EP0230179B1 (fr) 1992-09-30
JPS62148485A (ja) 1987-07-02
GR3006137T3 (pt) 1993-06-21
PT83920A (fr) 1987-01-01
US4736042A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
PT78682A (pt) Processo para a preparacao de novos derivados de 8-cloro-1,5-benzotiazepina e de composicoes farmaceuticas que os contem
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
PT94925A (pt) Processo para a preparacao de derivados de tiazol e de composicoes farmaceuticas que os contem
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
NO308792B1 (no) Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat
ES2113664T3 (es) Derivados de aminoacidos como inhibidores de la no sintasa.
PT83920B (pt) Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem
IE43847L (en) N-substituted phenylpiperidine derivatives.
PT81504B (pt) Processo para a preparacao de novos derivados de 9-cloro-1,5-benzotiazepina e de composicoes farmaceuticas que os contem
PT90635A (pt) Processo para a preparacao de derivados do acido n-(5,6,7,8-tetra-hidropirido-{2,3-d}pirimidin-6-il-alcanoil)glutamico
PT84680B (pt) Processo para a preparacao de derivados de 1,5-benzotiazepina e de composicoes farmaceuticas que os contem
ES2053780T3 (es) Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
PT90840A (pt) Processo para a preparcao de 3-aminosidnoniminas substituidas e de composicoes farmaceuticas que as contem
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
ES8106517A1 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
ZA811149B (en) Cyclohepitindolol derivatives and their salts with the acids, their preparation, their use as medicaments and the compositions containing them
SE8800846D0 (sv) Optiskt aktiva oxo-isoindolinderivat
KR900018083A (ko) 에폭시숙신산 유도체
PT81180B (pt) Novo processo para a preparacao de derivados do 4h-1,2,4-triazol e de composicoes farmaceuticas que os contem
DE3874920D1 (de) Benzimidazol-2-one-derivate, deren salze, verfahren und zwischenprodukte zu deren herstellung, deren anwendung als arzneimittel und sie enthaltende zusammensetzungen.
SE8303719D0 (sv) Novel eburnane oxime derivatives and process for preparing same
SE8601798D0 (sv) Process for the preparation of eburnamenine derivatives
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
YU46150B (sh) Racemski i optički aktivni derivati 14-hidrpksi-imino-eburnana kao i postupak za njihovo dobijanje
GB2282810A (en) Process for the preparation of clavulanic acid

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950630